Table 3.
Implementation effectiveness measures for self HIV Testing in Uganda
| Secondary outcomes | Unsupervised oral self HIV test N = 123 |
Provider supervised oral self HIV test N = 123 |
Proportion difference (%) (Exact, 90 % CI) |
Total (overall) | p value |
|---|---|---|---|---|---|
| Sensitivity (n/N,%) | |||||
| First time testers | 6/6 (100) | 7/7 (100) | 0 | 53 (21.5) | – |
| Repeat testers (>12 months) | 12/13 (92.3) | 6/6 (100) | −7.7 (−37.7–38.8) | 193 (78.5) | 0.6635 |
| Return rate (test validation and exit interview) (N, %) | 117 (95.1) | 123 (100) | −4.9 (−10.5–0.6) | 240 (95.8) | 0.0382 |
| Help requesteda (N, %) | 29 (23.6) | 51(41.5) | −17.9 (−29.7–5.5) | 240 (95.8) | 0.1708 |
| Observed performance error rate (N, %) | (N/A) | 24 (19.5) | – | 123 (50) | – |
| Linkage to Careb | |||||
| CD4 cell counts (N; median, IQR) | |||||
| Total (median, IQR) | N = 16; 418 (127–672) | N = 9; 551 (387–822) | – | N = 25; 452 (348–810) | 0.1374 |
| Among clients CD4 ≤500 | N = 10; 251 (68–410) | N = 4; 369 (328–439) | N = 14; 349 (101–410) | 0.0596 |
a
At least some form of help found necessary or help actually requested.
b
All 33 HIV positives referred for HIV care and treatment. CD4 Samples derived from 25 consenting participants